Viridian Therapeutics, Inc./DE Increase (Decrease) in Deposits
Viridian Therapeutics, Inc./DE (VRDN) reported Increase (Decrease) in Deposits of $28.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeposits · last filed 2017-03-24
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for the quarter ending 2014-12-31 was $1.00K, a 121.24% increase year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for the quarter ending 2013-12-31 was $452.00.
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for the quarter ending 2013-09-30 was $0.00.
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for fiscal 2015 was $28.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for fiscal 2014 was -$8.00K, a 172.73% decline from fiscal 2013.
- Viridian Therapeutics, Inc./DE increase (decrease) in deposits for fiscal 2013 was $11.00K.
| Period end | Increase (Decrease) in Deposits 3 month | Increase (Decrease) in Deposits 6 month | Increase (Decrease) in Deposits 9 month | Increase (Decrease) in Deposits 9 month as first filed | Increase (Decrease) in Deposits 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $28.00K 10-K · filed 2017-03-24 | |||
| 2015-09-30 | $28.00K 10-Q · filed 2016-10-26 | ||||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | -$8.00K 10-K · filed 2016-03-21 | |||
| 2014-09-30 | -$9.00K 10-Q · filed 2015-11-13 | -$8.29K 10-Q · filed 2014-11-14 | |||
| 2013-12-31 | $452.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $452.00 derived: sum of 2 quarters · filed 2015-03-27 | $11.00K 10-K · filed 2015-03-27 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $10.55K 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | $10.55K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |